Reports - Opioid Withdrawal Treatment Market
HealthcareOpioid Withdrawal Treatment Market
Opioid Withdrawal Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Medication-Assisted Treatment (MAT), Non-Medication-Based Therapy, Detoxification Treatment, Behavioral Therapy) by Drug Type (Buprenorphine, Methadone, Naltrexone, Clonidine, Lofexidine) by End-User (Hospitals & Clinics, Rehabilitation Centers, Homecare Settings, Specialty Treatment Centers) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Treatment Programs (Government and Private)) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Historic Data (2021 - 2023) & Forecast Period (2025 - 2035)
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. Global Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. Global Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. Global Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. Global Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. Global Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
7. Global Opioid Withdrawal Treatment Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. North America Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. North America Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. North America Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. North America Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. North America Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
Chapter 5 Europe Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. Europe Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. Europe Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. Europe Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. Europe Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. Europe Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
Chapter 6 Asia Pacific Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. Asia Pacific Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. Asia Pacific Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. Asia Pacific Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. Asia Pacific Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. Asia Pacific Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
Chapter 7 Latin America Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. Latin America Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. Latin America Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. Latin America Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. Latin America Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. Latin America Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
Chapter 8 Middle East & Africa Opioid Withdrawal Treatment Market - Segment Analysis
1. Overview
2. Middle East & Africa Opioid Withdrawal Treatment Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Opioid Withdrawal Treatment Market - by Treatment Type
3.1. By Medication-Assisted Treatment (MAT)
3.2. By Non-Medication-Based Therapy
3.3. By Detoxification Treatment
3.4. By Behavioral Therapy
4. Middle East & Africa Opioid Withdrawal Treatment Market - by Drug Type
4.1. By Buprenorphine
4.2. By Methadone
4.3. By Naltrexone
4.4. By Clonidine
4.5. By Lofexidine
5. Middle East & Africa Opioid Withdrawal Treatment Market - by End-User
5.1. By Hospitals & Clinics
5.2. By Rehabilitation Centers
5.3. By Homecare Settings
5.4. By Specialty Treatment Centers
6. Middle East & Africa Opioid Withdrawal Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
6.4. By Drug Treatment Programs (Government and Private)
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Indivior PLC
2. Alkermes PLC
3. BioDelivery Sciences International Inc.
4. Teva Pharmaceutical Industries Ltd.
5. Pfizer Inc.
6. Mallinckrodt Pharmaceuticals
7. Orexo AB
8. Hikma Pharmaceuticals
9. Viatris Inc. (formerly Mylan)
10. Purdue Pharma L.P.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By